Author:
Mr. Jeetu Gangil
Manipal College of Pharmaceutical Sciences, Manipal University, Karnataka
- Published By: Pharmanext. 2010; 59-62.
Introduction
In the upcoming era India is expected to be in the group of top 10 pharma markets by 2020. The Indian Pharmaceutical industry is on the threshold of becoming a global pharma hub. To capitalize on this opportunity India needs to build a strong research base. This growth include the marketed product portfolios, R&D pipelines, clinical research, market share data, sales forecasts and competitive landscape of the major players in the Indian pharma market. High-flying players in the Indian pharmaceutical market Like Ranbaxy Laboratories Limited, Cipla Limited, GlaxoSmithKline Pharmaceuticals Limited, Nicholas Piramal India Limited and Zydus Cadila. India is emerging as a competitive outsourcing hub and is playing a major role in the global pharmaceutical industry. Global pharmaceutical companies are establishing long-term relationships with Indian manufacturing companies and contract research providers in India. India emerging as a big global destination for contract manufacturing industry and it is growing at thrice the rate of the global outsourcing market.
No comments:
Post a Comment